PHMB Stock Price, Chart, Stats & News

PharmaCom BioVet, Inc.
Save
PharmaCom BioVet, Inc. (PHMB) does not currently pay a dividend.
1.08M
Market cap
–
Current P/E
–
Forward P/E
PHMB chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Care Facilities
Industry
PharmaCom BioVet, Inc. (PHMB) operates a network of specialized treatment centers across the United States, dedicated to veterinary oncology. The company's core mission involves advancing bone marrow transplantation and various other innovative cancer therapies for companion animals, particularly those diagnosed with lymphoma, other forms of cancer, and presently incurable conditions. To mitigate suffering in animals battling cancer, PharmaCom BioVet has secured licenses for proprietary medical devices and pharmaceutical compounds.
Similar securities
Based on sector and market capitalization
Report issue





